Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$15.15 - $19.78 $18.4 Million - $24.1 Million
-1,217,128 Closed
0 $0
Q4 2020

Feb 25, 2021

BUY
$16.86 - $19.67 $20.5 Million - $23.9 Million
1,214,609 Added 48217.9%
1,217,128 $22.4 Million
Q4 2020

Feb 12, 2021

SELL
$16.86 - $19.67 $3.63 Million - $4.23 Million
-215,185 Reduced 98.84%
2,519 $46,000
Q3 2020

Nov 12, 2020

SELL
$15.4 - $20.16 $15.4 Million - $20.1 Million
-996,905 Reduced 82.08%
217,704 $3.74 Million
Q2 2020

Aug 14, 2020

SELL
$18.24 - $21.45 $67,451 - $79,322
-3,698 Reduced 0.3%
1,214,609 $22.2 Million
Q1 2020

May 15, 2020

BUY
$16.28 - $25.63 $1,546 - $2,434
95 Added 0.01%
1,218,307 $24.6 Million
Q4 2019

Feb 14, 2020

SELL
$19.57 - $23.52 $23.8 Million - $28.6 Million
-1,215,005 Reduced 49.93%
1,218,212 $28.2 Million
Q3 2019

Nov 14, 2019

BUY
$19.85 - $22.76 $27.7 Million - $31.8 Million
1,395,403 Added 134.46%
2,433,217 $48.8 Million
Q2 2019

Aug 13, 2019

BUY
$17.59 - $21.1 $10 Million - $12 Million
569,607 Added 121.66%
1,037,814 $21.9 Million
Q1 2019

May 15, 2019

SELL
$18.01 - $20.11 $82,629 - $92,264
-4,588 Reduced 0.97%
468,207 $9.42 Million
Q4 2018

Feb 13, 2019

SELL
$17.44 - $21.53 $3.32 Million - $4.1 Million
-190,262 Reduced 28.69%
472,795 $8.68 Million
Q3 2018

Nov 13, 2018

SELL
$19.97 - $21.96 $6,390 - $7,027
-320 Reduced 0.05%
663,057 $14.2 Million
Q2 2018

Aug 10, 2018

BUY
$20.16 - $24.68 $3.69 Million - $4.51 Million
182,883 Added 38.06%
663,377 $14.3 Million
Q1 2018

May 11, 2018

BUY
$20.31 - $24.95 $104,007 - $127,768
5,121 Added 1.08%
480,494 $10.2 Million
Q4 2017

Feb 14, 2018

BUY
$20.99 - $23.89 $28,294 - $32,203
1,348 Added 0.28%
475,373 $10.9 Million
Q3 2017

Nov 14, 2017

BUY
$20.07 - $21.89 $20,852 - $22,743
1,039 Added 0.22%
474,025 $10.4 Million
Q2 2017

Aug 14, 2017

BUY
N/A
472,986
472,986 $9.99 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.33B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.